Mental health stocks: Innovation and M&A to boost these stocks
Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit.
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit.
Wealth Alliance cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 4.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,735 shares of the company’s stock after selling 541 shares during the period. Wealth Alliance’s holdings in Johnson & Johnson were […]
Guerra Pan Advisors LLC cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,365 shares of the company’s stock after selling 522 shares during the quarter. Guerra Pan Advisors LLC’s […]
Vaughan Nelson Investment Management L.P. lowered its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.6% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 720,571 shares of the company’s stock after selling 198,325 shares during the quarter. Johnson & Johnson accounts for […]
Blair William & Co. IL trimmed its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 965,580 shares of the company’s stock after selling 40,054 shares during the quarter. Blair William […]